Literature DB >> 22607468

Pyoderma gangrenosum in association with Janus kinase 2 (JAK2V617F) mutation.

J A Palanivel1, A E Macbeth, N J Levell.   

Abstract

Pyoderma gangrenosum (PG) commonly occurs in association with various haematological and inflammatory disorders. We report a new association, a Janus kinase (JAK)2 mutation, in a 63-year-old patient with PG. We hypothesise that PG occurs by direct activation of JAK along with signal transducers and activators of transcription (STAT), a common mechanism involved in the pathogenesis of inflammatory and haematological diseases. © The Author(s). CED
© 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607468     DOI: 10.1111/j.1365-2230.2012.04375.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  A Comprehensive Review of Neutrophilic Diseases.

Authors:  Angelo V Marzano; Alessandro Borghi; Daniel Wallach; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  [Acute lymphoblastic leukemia complicated with pyoderma gangrenosum: a case report and literatures review].

Authors:  X Shi; Z G Cui; F Hou; H Xu; H Wang; Z Su; H G Zhao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14

Review 3.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.